aryl-aryl couplings under relatively high temperatures in
the further synthesis, an alternative bidirectional strategy8
based on a Zinin rearrangement was thus developed in our
successful synthesis of the dimeric core amino acid derivative
2 (Figure 1) in 2006.7 In this communication, we report our
achievement in the total synthesis of chloptosin using a
bidirectional strategy.
Although the core amino acid derivative 3 (Figure 1)
suitable for further synthesis could be prepared after
several transformations from acid 2,7 relatively longer
steps and lower overall yield made it disadvantageous in
the material accumulation. Improvement of our previous
synthesis of this core amino acid7 was decided as the
starting point of this work. Because both reactants are
readily available, palladium-catalyzed heteroannulation9
of 2,2′-dichloro-5,5′-diiodobiphenyl-4,4′-diamine 47 and
L-pyroglutamic acid derivative 510 was then employed as
a shortcut to the requested bis-tryptophan intermediate 6a.
After careful optimization of reaction conditions, a mixture
of the needed dimeric tryptophan derivative 6a and meso-
product 6b was afforded in 42% combined yield (Scheme
1, 6a:6b > 4:1, measured by chiral HPLC). The corre-
Figure 1. Structure of chloptosin (1) and its unique core amino
acid (derivatives 2 and 3).
meric amino acid and several other unusual amino acids.
Structurally, it is similar to a previously reported natural
product himastantin, whose structure was revised via a
total synthesis by Danishefsky in 1998.4 Besides some
amino acid components, a major difference between these
two natural compounds is the central core amino acid.
Two additional chlorines are symmetrically embraced in
the diphenyl moiety of chloptosin (1) in this case. Though
a sound number of other natural products have been
isolated having the pyrroloindole architecture,5 the pres-
ence of a chlorine atom at the 6-position is apparently
rare. In addition, existence of two vicinal piperazine-3-
carboxylic acids in the cyclopeptide subunits further makes
chloptosin more spatially crowded than himastatin. All
these characteristics of the molecular architecture of
chloptosin including crowded spatial environment would
bring about some uncertain challenges during its total
synthesis, especially in the peptide couplings and the
macrocyclization.
Scheme 1. One-Step Synthesis of the Dimeric
6-Chlorotryptophan Derivatives 6a and 6b
For its unique structure and promising biological proper-
ties, chloptosin has attracted sound attentions in organic
synthesis. Several methodology developments6 and one
synthesis of the central amino acid7 have been reported in
recent years. Due to the presence of 6-chlorine, a number of
our initial attempts failed in the Csp2-Csp2 couplings to the
diphenyl core under various metal-catalyzed conditions.
Considering the stability of peptide substrates in those
sponding reaction with aldehyde 5′ gave much lower yield.
Diastereomers 6a and 6b are inseparable by silica gel
chromatography. Because of the poor resolution under
chiral HPLC conditions, the enantio purity of 6a was
finally dertemined after several further transformations
(see below text).
After treatment of the mixture of 6a/6b with Boc2O,
the resulting mixture of 7a/7b was then subjected to the
reaction with N-phenylselenophthalimide (N-PSP),11 pro-
(4) (a) Kamenecka, T. M.; Danishefsky, S. J. Angew. Chem., Int. Ed.
1998, 37, 2993–2995. (b) Kamenecka, T. M.; Danishefsky, S. J. Angew.
Chem., Int. Ed. 1998, 37, 2995–2998. (c) Kamenecka, T. M.; Danishefsky,
S. J. Chem.sEur. J. 2001, 7, 41–63.
(5) (a) Depew, K. M.; Marsden, S. P.; Zatorska, D.; Zatorski, A.;
Bornmann, W. G.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11953–
11963. (b) Nishida, A.; Ushigome, S.; Sugimoto, A.; Arai, S. Heterocycles
2005, 66, 181–185. (c) Iwaki, T.; Yamada, F.; Funaki, S.; Somei, M.
Heterocyles 2005, 65, 1811–1815. (d) Kawahara, M.; Nishida, A.; Naka-
gawa, M. Org. Lett. 2000, 2, 675–678. (e) Sun, W. Y.; Sun, Y.; Tang,
Y. C.; Hu, J. Q. Synlett 1993, 337–338.
(8) A review on the bidirectional synthesis, see: Poss, C. S.; Schreiber,
S. L. Acc. Chem. Res. 1994, 27, 9–17.
(6) (a) Hong, W.-X.; Yao, Z.-J. Chin. J. Chem. 2004, 22, 365–370. (b)
Kim, Y.-A.; Han, S.-Y. Synth. Commun. 2004, 34, 2931–2943.
(7) Hong, W. X.; Chen, L. J.; Zhong, C. L.; Yao, Z.-J. Org. Lett. 2006,
8, 4919–4922.
(9) Xia, Y. X.; Zhu, J. P. Synlett 2005, 16, 2469–2472.
(10) (a) August, R. A.; Khan, J. A.; Moody, C. M.; Young, D. W.
J. Chem. Soc., Perkin Trans. I. 1996, 507–514. (b) Johannesson, P. J. Med.
Chem. 1999, 42, 4524–4537.
Org. Lett., Vol. 12, No. 5, 2010
1125